Unknown

Dataset Information

0

ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine.


ABSTRACT:

Background

Triple-negative breast cancer (TNBC) is often aggressive and associated with a poor prognosis. Due to the lack of available targeted therapies and to problems of resistance with conventional chemotherapeutic agents, finding new treatments for TNBC remains a challenge and a better therapeutic strategy is urgently required.

Methods

TNBC cells and xenograft mice were treated with a combination of chloroquine (CQ) and isorhamnetin (IH). Mitochondrial fission, apoptosis, and related signaling pathways were determined by flow cytometry, immunofluorescence, and related molecular biological techniques.

Results

The inhibition of autophagy/mitophagy by CQ selectively enhances IH-induced mitochondrial fission and apoptosis in TNBC cells but not in estrogen-dependent breast cancer cells. These events were accompanied by mitochondrial translocation of Bax and the release of cytochrome c. Mechanistically, these effects were associated with oxidative stress-mediated phosphorylation of CaMKII (Thr286) and Drp1 (S616), and subsequent mitochondrial translocation of CaMKII and Drp1. The interruption of the CaMKII pathway by genetic approaches (e.g. CaMKII mutant or siRNA) attenuated combination-mediated mitochondrial fission and apoptosis. The combination of CQ/IH was a marked inhibitor tumor growth, inducing apoptosis in the TNBC xenograft mouse model in association with the activation of CaMKII and Drp1 (S616).

Conclusions

Our study highlights the critical role of ROS-mediating CaMKII/Drp1 signaling in the regulation of mitochondrial fission and apoptosis induced by combination of CQ/IH. These findings also suggest that IH could potentially be further developed as a novel chemotherapeutic agent. Furthermore, a combination of IH with classic autophagy/mitophagy inhibitor could represent a novel therapeutic strategy for the treatment of TNBC.

SUBMITTER: Hu J 

PROVIDER: S-EPMC6540563 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine.

Hu Jinjiao J   Zhang Yanhao Y   Jiang Xiuxing X   Zhang Hongwei H   Gao Ziyi Z   Li Yunong Y   Fu Ruoqiu R   Li Lirong L   Li Jie J   Cui Hongjuan H   Gao Ning N  

Journal of experimental & clinical cancer research : CR 20190528 1


<h4>Background</h4>Triple-negative breast cancer (TNBC) is often aggressive and associated with a poor prognosis. Due to the lack of available targeted therapies and to problems of resistance with conventional chemotherapeutic agents, finding new treatments for TNBC remains a challenge and a better therapeutic strategy is urgently required.<h4>Methods</h4>TNBC cells and xenograft mice were treated with a combination of chloroquine (CQ) and isorhamnetin (IH). Mitochondrial fission, apoptosis, and  ...[more]

Similar Datasets

| S-EPMC4359335 | biostudies-literature
| S-EPMC8168414 | biostudies-literature
| S-EPMC7422600 | biostudies-literature
| S-EPMC8115655 | biostudies-literature
| S-EPMC3934017 | biostudies-literature
| S-EPMC10206500 | biostudies-literature
| S-EPMC4666140 | biostudies-literature
| S-EPMC5680571 | biostudies-literature
| S-EPMC7564485 | biostudies-literature
| S-EPMC5131733 | biostudies-literature